Abstract:Abstract Motivation Drug repositioning is an attractive alternative to de novo drug discovery due to reduced time and costs to bring drugs to market. Computational repositioning methods, particularly non-black-box methods that can account for and predict a drug’s mechanism, may provide great benefit for directing future development. By tuning both data and algorithm to utilize relationships important to drug mechanisms, a computational repositioning algorithm can be trained to both predict and explain mechanistically novel indications. Results In this work, we examined the 123 curated drug mechanism paths found in the drug mechanism database (DrugMechDB) and after identifying the most important relationships, we integrated 18 data sources to produce a heterogeneous knowledge graph, MechRepoNet, capable of capturing the information in these paths. We applied the Rephetio repurposing algorithm to MechRepoNet using only a subset of relationships known to be mechanistic in nature and found adequate predictive ability on an evaluation set with AUROC value of 0.83. The resulting repurposing model allowed us to prioritize paths in our knowledge graph to produce a predicted treatment mechanism. We found that DrugMechDB paths, when present in the network were rated highly among predicted mechanisms. We then demonstrated MechRepoNet’s ability to use mechanistic insight to identify a drug’s mechanistic target, with a mean reciprocal rank of .525 on a test set of known drug-target interactions. Finally, we walked through a repurposing example of the anti-cancer drug imantinib for use in the treatment of asthma, to demonstrate this method’s utility in providing mechanistic insight into repurposing predictions it provides. Availability and implementation The Python code to reproduce the entirety of this analysis is available at: https://github.com/SuLab/MechRepoNet Contact asu@scripps.edu Supplementary information Supplemental information is available at Bioinformatics online.

In silico prediction of chemical mechanism-of-action via an improved network-based inference method.

Sdtnbi: an Integrated Network and Chemoinformatics Tool for Systematic Prediction of Drug-Target Interactions and Drug Repositioning

Prediction of Drug-Target Interactions and Drug Repositioning Via Network-Based Inference

Computational Prediction of DrugTarget Interactions Using Chemical, Biological, and Network Features

Predicting Drug-Target Interactions Via Within-Score and Between-Score

Computational Prediction of DrugTarget Interactions Using Chemical, Biological, and Network Features

Prediction of Chemical-Protein Interactions Network with Weighted Network-Based Inference Method

Open MoA: revealing the mechanism of action (MoA) based on network topology and hierarchy

Network-Based Methods for Prediction of Drug-Target Interactions

Design and application of a knowledge network for automatic prioritization of drug mechanisms

In-silico Target Prediction by Ensemble Chemogenomic Model Based on Multi-Scale Information of Chemical Structures and Protein Sequences.

Drug–Target Interaction Prediction Based on an Interactive Inference Network

Predicting drug target interactions using meta-path-based semantic network analysis

Synergizing Chemical Structures and Bioassay Descriptions for Enhanced Molecular Property Prediction in Drug Discovery

A Systematic Prediction Of Multiple Drug-Target Interactions From Chemical, Genomic, And Pharmacological Data

Author Correction: Prediction of New Drug Indications Based on Clinical Data and Network Modularity

BioChemDDI: Predicting Drug–Drug Interactions by Fusing Biochemical and Structural Information through a Self-Attention Mechanism

Predicting Drug-Target Interaction Networks Based on Functional Groups and Biological Features.

Prediction of Drug Synergy and Antagonism Based on Drug-Drug Interaction Network

Synergy evaluation by a pathway-pathway interaction network: a new way to predict drug combination.

An In Silico Method for Predicting Drug Synergy Based on Multitask Learning